Finance

Beta
Lists
KYMR:NASDAQ
Kymera Therapeutics Inc
$74.13
-0.64%
(-0.48) 1D
$74.13
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KYMR...
Open
$74.36
High
$75.38
Low
$72.77
Mkt. cap
6.10B
Avg. vol.
530.05K
Volume
639.45K
52-wk high
$103.00
52-wk low
$36.65
EPS
-$3.57
Beta
2.02
Shares outstanding
82.26M
No. of employees
253
Open
$74.36
High
$75.38
Low
$72.77
Mkt. cap
6.10B
Avg. vol.
530.05K
Volume
639.45K
52-wk high
$103.00
52-wk low
$36.65
EPS
-$3.57
Beta
2.02
Shares outstanding
82.26M
No. of employees
253
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to KYMR in the past 3 months
Strong Buy
Buy
10
Hold
0
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for KYMR in the last 3 months.
Highest
Current $74.13
$134.00 (+80.76%)
Average
$119.13 (+60.70%)
Lowest
$106.00 (+42.99%)
News stories
From sources across the web
About Kymera Therapeutics Inc
CEO-
Employees253
Founded2015
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websitekymeratx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
11.48M
2.76M
2.87M
34.36M
Cost of goods sold
78.39M
74.09M
83.83M
98.16M
Cost of revenue
78.39M
74.09M
83.83M
98.16M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.64M
17.34M
16.94M
20.36M
Operating expense
17.64M
17.34M
16.94M
20.36M
Total operating expenses
96.03M
91.43M
100.77M
118.52M
Operating income
-84.56M
-88.67M
-97.90M
-84.15M
Other non operating income
-
-
-
5.00K
EBT including unusual items
-76.61M
-82.18M
-86.98M
-69.23M
EBT excluding unusual items
-76.61M
-78.32M
-86.98M
-69.23M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-76.61M
-82.18M
-86.98M
-69.23M
Net profit margin
-667.60%
-2,973.05%
-3,030.70%
-201.47%
Earnings per share
-0.95
-0.94
-0.98
-0.71
Interest and investment income
8.05M
10.44M
11.00M
14.98M
Interest expense
-108.00K
-98.00K
-90.00K
-66.00K
Net interest expenses
7.94M
10.35M
10.92M
14.92M
Depreciation and amortization charges
-
-
-
-
EBITDA
-83.17M
-85.82M
-97.46M
-82.13M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer